Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 319 of 6351
-
New ER discharge plan aims to stop opioid overdose deaths
Disease control Not yet recruitingOpioid overdose deaths have reached historically high records in the United States and are particularly concentrated among patients after emergency department (ED) discharge. Evidence-based treatment modules to reduce repeat opioid overdose and mortality are lacking in this patie…
Phase 4 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a vitamin B3 tablet help restore energy in long COVID?
Symptom relief Not yet recruitingIn patients with post-COVID syndrome, changes in tryptophan metabolism, energy metabolism, and the gut microbiome may occur. In an earlier nutritional study, patients with COVID-19 recovered their physical performance more quickly when taking nicotinamide (vitamin B3). Patients w…
Sponsor: University Hospital Schleswig-Holstein • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Could a simple education program be the key to better hip fracture recovery?
Symptom relief Recruiting nowThis randomized controlled trial aims to evaluate the effect of a structured patient-centered educational program on postoperative outcomes among patients undergoing hip fracture surgery. Participants will be randomly assigned to either an intervention group receiving the educati…
Sponsor: Assiut University • Aim: Symptom relief
Last updated Sep 10, 2026 04:00 UTC
-
Can a safer opioid choice stop Kids' Post-Surgery agitation?
Symptom relief Not yet recruitingEmergence delirium (agitation) is a common complication in children recovering from general anesthesia, especially after sevoflurane. Affected children wake in a dissociative state - restless, crying, inconsolable, unaware of their surroundings - with a reported incidence of 25-8…
Phase 4 • Sponsor: Konya City Hospital • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Smartwatch signals may flag anemia, no needle needed
Diagnosis Not yet recruitingAnemia is a common condition, but it often goes undiagnosed because confirming it requires a venous blood test. This study looks at whether a commercially available wrist-worn smartwatch can help identify people who may have anemia, without taking blood. The watch continuously r…
Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
Can a simple patch stop diabetes device skin woes?
Disease control Recruiting nowThe goal of this clinical trial is to ensure that contact dermatitis does not prevent any person with diabetes from accessing optimal diabetes treatment. The main questions this study aims to answer are: How many pediatric patients with diabetes device-related contact dermatiti…
Sponsor: Steno Diabetes Center Copenhagen • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Engineered herpes virus takes aim at Hard-to-Treat cancers
Disease control Not yet recruitingVG2025 is a Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection. This Phase I study will be conducted in herpes simplex virus (HSV) -seropositive subjects with advanced malignant solid tumors that are refractory to conventional therapies. This is an open label stud…
Phase 1/2 • Sponsor: Virogin Biotech Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a new pill outsmart RAS-Mutant cancers?
Disease control Not yet recruitingThe purpose of this study is to test if the BG-85738 is safe and if it works in patients with advanced solid tumors with RAS mutations when it is given on its own and in combination.
Phase 1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Brain waves and beats: a new hope for test stress?
Symptom relief Recruiting nowAcademic anxiety is one of the most prevalent psychological challenges among adolescents and has been associated with impaired executive functioning, attentional control, autonomic dysregulation, and reduced creative performance. Although neurofeedback and audiovisual entrainment…
Sponsor: Daniswara Raditya Suprapto • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Could a pill help tackle obesity? new drug enters human testing
Disease control Not yet recruitingThis trial is conducted in China. This study plans to include 2 parts, i.e., a single-dose study and a multiple-dose study: The single-dose study will be conducted in healthy adult participants to evaluate the safety, tolerability, and pharmacokinetic profile of single doses of …
Phase 1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a 3-Day course transform care for people with disabilities?
Knowledge-focused Recruiting nowThis randomized controlled trial will evaluate the efficacy of a three-day sexual and reproductive health curriculum focused on persons with disabilities and tailored to the Tanzanian context. The intervention will be delivered to medical, nursing, and midwifery students at Muhi…
Phase 3 • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Can a new Under-the-Tongue drug offer lasting relief for Treatment-Resistant anxiety?
Disease control Recruiting nowThe purpose of this study is to assess how safe ITI-1284 is and how well it can be tolerated in long-term, when given alone or with other medicines, in participants with generalized anxiety disorder (GAD) who have not responded to treatment previously. GAD is a mental health cond…
Phase 3 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New cocktail aims to tame myeloma without transplant
Disease control Not yet recruitingThis study is to evaluate the combination of isatuximab, iberdomide, bortezomib, and dexamethasone in newly diagnosed multiple myeloma participants who are transplant ineligible or not intended for upfront transplant. The names of the study drugs used in this research study are:…
Phase 1/2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Brain games may rev up thinking and driving after cancer treatment
Symptom relief Not yet recruitingThe goal of the study is to understand how well cognitive training improves reaction time in people with head and neck cancer (HNC). Aim 1. Evaluate the preliminary clinical effectiveness of a 10-week home- and video game-based SOPT on cognitive functioning and driving performanc…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
New drug aims to ease anemia in bone marrow cancer patients
Disease control Recruiting nowThe main aim of this study is to find out how well elritercept works to improve anemia in participants with myelofibrosis (MF) who are taking ruxolitinib when compared to placebo. Other aims are to learn how elritercept improves anemia compared to placebo; to learn if elritercep…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Mind over ache: could meditation tame MS pain?
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate whether a mindfulness-based intervention is effective for reducing pain in adults with multiple sclerosis. It will also assess whether this intervention improves other symptoms commonly associated with pain, such as fatigue, sleep di…
Sponsor: Hospital Universitario Virgen Macarena • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Can a pill replace the shot for weight loss?
Disease control Not yet recruitingThe goal of this study is to learn about the safety and tolerability of IBI3042, an investigational oral drug that activates the glucagon-like peptide-1 (GLP-1) receptor. The study will also assess how IBI3042 moves through the body and explore its effects on body weight and rela…
Phase 1 • Sponsor: Hongwei Jiang • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can targeted exercises boost balance in children with down syndrome?
Disease control Not yet recruitingThis study will compare the effects of vestibular stimulation exercises and foot intrinsic muscle exercises on balance and functional mobility in children with Down syndrome aged 4-15 years. Children with Down syndrome commonly experience balance and mobility difficulties due to …
Sponsor: Shalamar Institute of Health Sciences • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a new catheter zap away irregular heartbeats?
Disease control Not yet recruitingThe goal of this clinical trial is to find out if the Sphere-9 Catheter and Affera Integrated Mapping and Ablation System is safe and works to treat recurrent symptomatic paroxysmal atrial fibrillation (PAF) in adults who have not been helped by, cannot tolerate, or cannot take c…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
First-of-its-kind online program aims to prevent sexual assault among trans undergraduates
Prevention Not yet recruitingThe purpose of this study is to adapt and pilot a sexual assault prevention intervention for transgender and nonbinary (trans) undergraduate students. Forty percent of trans individuals (i.e., individuals whose gender identity does not align with their sex assigned at birth, incl…
Sponsor: Sarah Peitzmeier • Aim: Prevention
Last updated Jul 17, 2026 00:00 UTC